Clinical Research Directory

Inclusion Criteria: * Non-pregnant and non-lactating * English speaking with the ability to give informed consent * 18-35 years of age (inclusive) * Women who are biologically female * Iron deficient (SF \>/=12μg/L and \</=30 μg/L). Note: there is currently poor consensus on diagnostic criteria for iron deficiency based on SF concentrations. Current recommendations range from 15 μg/L to 100 μg/L. * Hb \>/=110 g/L * Willing and able to agree to the requirements and lifestyle restrictions of this study * Able to understand and read the questionnaires in English and carry out all study-related procedures * Located in the greater Ottawa area and a resident of Ontario Exclusion Criteria: * Individuals who are lactating, pregnant, or planning to become pregnant during the study * Individuals who are not maintaining adequate birth control measures * Adequate birth control measures include any option that will adequately prevent pregnancy including: contraceptives, lifestyle choices, complete abstinence, or as a result of other medical methods, procedures, or conditions * Have a known sensitivity, intolerability, or allergy to any of the study products or their excipients * Are using vitamin and mineral supplements containing iron and/or zinc * SF concentrations \<12 μg/L or \>30 μg/L * Having moderate or severe anaemia (Hb \<109 g/L) * Expecting to change diet and exercise regimen in the next 6 months * Are frequent blood donors * Have donated blood in the last four months * Donate blood more than two to three times per year * Had major surgery in the past three months * Have planned surgery during the course of the study * History of problematic alcohol or substance use in the 12 months prior to screening (including having been hospitalized for such in an in-patient or out-patient intervention program) * Use of investigational product(s) in another research study within 30 days prior to the baseline visit or during the study duration * Using any of the following drugs: * Antacids or proton pump inhibitors, H2 blockers * Salicylates, aspirin, corticosteroids, nonsteroidal anti-inflammatory drugs * Anticoagulants, antiplatelet compounds * Drugs with known contraindication with iron supplementation or fortification * Antiviral medications * Levothyroxine (Synthroid) * Known medical history of specific conditions including: * Gastrointestinal disorders: celiac disease, ulcerative colitis, and Crohn's disease * Gastric cancer and gastric polyps * Colon cancer * Diverticular bleeding * Inflammatory bowel diseases * Angiodysplasia * Helicobacter pylori infection * Hookworm (Ancylostoma duodenale and Necator americanus) * Defects of hemostasis (hereditary hemorrhagic telangectasia, von Willebrand disease) * Gastrectomy, duodenal bypass, bariatric surgery * Erythropoiesis-stimulating agent therapy * Chronic kidney disease * Hemochromatosis * Hemoglobinopathies * Blood clotting disorder * Have any other active or unstable medical conditions or use of medications/supplements/ therapies that according to the scientific literature, may adversely affect the participant's ability to complete the study or its measures or pose a significant risk to the participant or the quality of the study data.